101 Radical radiotherapy outcomes for non-small cell lung cancer (NSCLC) - Barts experience 2000-2008 (English)
- New search for: Eminowicz, G.
- New search for: Raman, R.
- New search for: Tarver, K.
- New search for: Wells, P.
- New search for: Eminowicz, G.
- New search for: Raman, R.
- New search for: Tarver, K.
- New search for: Wells, P.
In:
LUNG CANCER -AMSTERDAM-
;
71
;
S35
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:101 Radical radiotherapy outcomes for non-small cell lung cancer (NSCLC) - Barts experience 2000-2008
-
Contributors:
-
Published in:LUNG CANCER -AMSTERDAM- ; 71 ; S35
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2011-01-01
-
Size:S35
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99424
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99424 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 71
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Surgery and mesothelioma: If not randomization, at least standardization and registration!Pass, H. et al. | 2011
- 3
-
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLCChang, A. et al. | 2011
- 11
-
The function of IGF-IR in NNK-mediated lung tumorigenesisSiwicky, M. D. / Petrik, J. J. / Moorehead, R. A. et al. | 2011
- 19
-
Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinomaShinmura, K. / Tao, H. / Nagura, K. / Goto, M. / Matsuura, S. / Mochizuki, T. / Suzuki, K. / Tanahashi, M. / Niwa, H. / Ogawa, H. et al. | 2011
- 28
-
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancerSu, W. P. / Chen, Y. T. / Lai, W. W. / Lin, C. C. / Yan, J. J. / Su, W. C. et al. | 2011
- 34
-
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lungTsuta, K. / Raso, M. G. / Kalhor, N. / Liu, D. D. / Wistuba, I. I. / Moran, C. A. et al. | 2011
- 42
-
Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humansKurotani, R. / Kumaki, N. / Naizhen, X. / Ward, J. M. / Linnoila, R. I. / Kimura, S. et al. | 2011
- 49
-
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapyImamura, Y. / Azuma, K. / Kurata, S. / Hattori, S. / Sasada, T. / Kinoshita, T. / Okamoto, M. / Kawayama, T. / Kaida, H. / Ishibashi, M. et al. | 2011
- 55
-
A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean resultsChoi, H. J. / Sohn, J. H. / Lee, C. G. / Shim, H. S. / Lee, I. J. / Yang, W. I. / Kwon, J. E. / Kim, S. K. / Park, M. S. / Lee, J. H. et al. | 2011
- 60
-
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancerOkayama, L. C. / Takigawa, N. / Kiura, K. / Hotta, K. / Hosokawa, S. / Nogami, N. / Aoe, K. / Gemba, K. / Fujiwara, K. / Harita, S. et al. | 2011
- 65
-
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutationsKim, D. W. / Lee, S. H. / Lee, J. S. / Lee, M. A. / Kang, J. H. / Kim, S. Y. / Shin, S. W. / Kim, H. K. / Heo, D. S. et al. | 2011
- 70
-
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasMinegishi, Y. / Sudoh, J. / Kuribayasi, H. / Mizutani, H. / Seike, M. / Azuma, A. / Yoshimura, A. / Kudoh, S. / Gemma, A. et al. | 2011
- 75
-
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapyBolukbas, S. / Manegold, C. / Eberlein, M. / Bergmann, T. / Fisseler-Eckhoff, A. / Schirren, J. et al. | 2011
- 82
-
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapyPu, X. / Hildebrandt, M. A. / Lu, C. / Lin, J. / Stewart, D. J. / Ye, Y. / Gu, J. / Spitz, M. R. / Wu, X. et al. | 2011
- 89
-
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastasesSun, J. M. / Ahn, J. S. / Lee, S. / Kim, J. A. / Lee, J. / Park, Y. H. / Park, H. C. / Ahn, M. J. / Ahn, Y. C. / Park, K. et al. | 2011
- 94
-
A qualitative exploration of a respiratory distress symptom cluster in lung cancer: Cough, breathlessness and fatigueMolassiotis, A. / Lowe, M. / Blackhall, F. / Lorigan, P. et al. | 2011
- 103
-
Health-related quality of life among early-stage, non-small cell, lung cancer survivorsOstroff, J. S. / Krebs, P. / Coups, E. J. / Burkhalter, J. E. / Feinstein, M. B. / Steingart, R. M. / Logue, A. E. / Park, B. J. et al. | 2011
- 109
-
Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutationDisel, U. / Oztuzcu, S. / Besen, A. A. / Karadeniz, C. / Kose, F. / Sumbul, A. T. / Sezer, A. / Nursal, G. N. / Abali, H. / Ozyilkan, O. et al. | 2011
- 113
-
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesotheliomaAmatori, S. / Bagaloni, I. / Viti, D. / Fanelli, M. et al. | 2011
- 115
-
Mutation analysis of the FRK gene in non-small cell lung cancersJin, G. / Jeon, H. S. / Yang, E. / Park, J. Y. et al. | 2011
- 118
-
Corrigendum to ''Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy'' [Lung Cancer 69S1 (2010) S11-S18]Giuliani, G. / Grossi, F. / de Marinis, F. / Walzer, S. et al. | 2011
- 119
-
Acknowledgement to Reviewers 2010| 2011
- 123
-
A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancerHart, K. / Landvik, N. E. / Lind, H. / Skaug, V. / Haugen, A. / Zienolddiny, S. et al. | 2011
- 130
-
Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNPKristensen, L. S. / Nielsen, H. M. / Hager, H. / Hansen, L. L. et al. | 2011
- 137
-
Correlations between thin-section CT findings, histopathological and clinical findings of small pulmonary adenocarcinomasSaito, H. / Kameda, Y. / Masui, K. / Murakami, S. / Kondo, T. / Ito, H. / Oshita, F. / Tsuboi, M. / Yokose, T. / Noda, K. et al. | 2011
- 144
-
Biologic correlates of ^1^8F-FDG uptake on PET in pulmonary pleomorphic carcinomaKaira, K. / Endo, M. / Abe, M. / Nakagawa, K. / Ohde, Y. / Okumura, T. / Takahashi, T. / Murakami, H. / Tsuya, A. / Nakamura, Y. et al. | 2011
- 151
-
A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patientsDavies, J. M. / Dhruva, N. S. / Walko, C. M. / Socinski, M. A. / Bernard, S. / Hayes, D. N. / Kim, W. Y. / Ivanova, A. / Keller, K. / Hilbun, L. R. et al. | 2011
- 156
-
Local failure after complete resection of N0-1 non-small cell lung cancerSaynak, M. / Veeramachaneni, N. K. / Hubbs, J. L. / Nam, J. / Qaqish, B. F. / Bailey, J. E. / Chung, W. / Marks, L. B. et al. | 2011
- 166
-
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study GroupHallqvist, A. / Wagenius, G. / Rylander, H. / Brodin, O. / Holmberg, E. / Loden, B. / Ewers, S. B. / Bergstrom, S. / Wichardt-Johansson, G. / Nilsson, K. et al. | 2011
- 173
-
Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or moreTamiya, A. / Naito, T. / Ono, A. / Ayabe, E. / Tsuya, A. / Nakamura, Y. / Kaira, K. / Murakami, H. / Takahashi, T. / Endo, M. et al. | 2011
- 178
-
Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancerHillerdal, G. / Sederholm, C. / Andersson, K. et al. | 2011
- 182
-
Role of emphysema and airway obstruction in prognosis of lung cancerGullon, J. A. / Suarez, I. / Medina, A. / Rubinos, G. / Fernandez, R. / Gonzalez, I. et al. | 2011
- 186
-
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancerKim, A. W. / Batus, M. / Myint, R. / Fidler, M. J. / Basu, S. / Bonomi, P. / Faber, L. P. / Wightman, S. C. / Warren, W. H. / McIntire, M. et al. | 2011
- 191
-
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbineon behalf, o. t. / Vinolas, N. / Provencio, M. / Reguart, N. / Cardenal, F. / Alberola, V. / Sanchez-Torres, J. M. / Baron, F. J. / Cobo, M. / Maestu, I. et al. | 2011
- 199
-
A pilot study of mRNA expressions of 5-fluorouracil pathway genes in peripheral blood mononuclear cells and tumor tissues in patients with lung adenocarcinomaOgata, S. / Ozeki, Y. / Nakanishi, K. / Fujita, Y. / Tanaka, F. / Hasegawa, S. / Mio, T. / Wada, H. / Hiroi, S. / Tominaga, S. et al. | 2011
- 205
-
Growth rate of newly developed metastatic brain tumors after thoracotomy in patients with non-small cell lung cancerYoo, H. / Jung, E. / Nam, B. H. / Shin, S. H. / Gwak, H. S. / Kim, M. S. / Zo, J. I. / Lee, S. H. et al. | 2011
- 209
-
TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patientsYoon, S. O. / Kim, Y. T. / Jung, K. C. / Jeon, Y. K. / Kim, B. H. / Kim, C. W. et al. | 2011
- 217
-
Exponential decay nonlinear regression analysis of patient survival curves: Preliminary assessment in non-small cell lung cancerStewart, D. J. / Behrens, C. / Roth, J. / Wistuba, I. I. et al. | 2011
- 224
-
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?Hirose, T. / Okuda, K. / Yamaoka, T. / Ishida, K. / Kusumoto, S. / Sugiyama, T. / Shirai, T. / Ohnshi, T. / Ohmori, T. / Adachi, M. et al. | 2011
- 229
-
Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: Randomised controlled trialArbane, G. / Tropman, D. / Jackson, D. / Garrod, R. et al. | 2011
- 235
-
Repressive coping style: Relationships with depression, pain, and pain coping strategies in lung cancer out patientsPrasertsri, N. / Holden, J. / Keefe, F. J. / Wilkie, D. J. et al. | 2011
- 241
-
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutationsTiseo, M. / Gelsomino, F. / Boggiani, D. / Bortesi, B. / Bartolotti, M. / Bozzetti, C. / Sammarelli, G. / Thai, E. / Ardizzoni, A. et al. | 2011
- 244
-
Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and GermanyBosch-Barrera, J. / Gil-Bazo, I. et al. | 2011
- 245
-
Response to Letter to the EditorBischoff, H. G. / Heigener, D. F. / Walzer, S. / Nuijten, M. et al. | 2011
- 247
-
Lung cancer screening: What is the benefit and what do we do about it?Mulshine, J. L. / van Klaveren, R. J. et al. | 2011
- 249
-
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidenceGridelli, C. / De Marinis, F. / Di Maio, M. / Cortinovis, D. / Cappuzzo, F. / Mok, T. et al. | 2011
- 258
-
Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in womenPaulus, J. K. / Zhou, W. / Kraft, P. / Johnson, B. E. / Lin, X. / Christiani, D. C. et al. | 2011
- 264
-
Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cellsUppstad, H. / Osnes, G. H. / Cole, K. J. / Phillips, D. H. / Haugen, A. / Mollerup, S. et al. | 2011
- 271
-
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancerChougule, M. / Patel, A. R. / Sachdeva, P. / Jackson, T. / Singh, M. et al. | 2011
- 283
-
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitorsMorgillo, F. / D'Aiuto, E. / Troiani, T. / Martinelli, E. / Cascone, T. / De Palma, R. / Orditura, M. / De Vita, F. / Ciardiello, F. et al. | 2011
- 291
-
Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cellsLin, Y. / Wang, Z. / Liu, L. / Chen, L. et al. | 2011
- 298
-
Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucinAbdull Razis, A. F. / Bagatta, M. / De Nicola, G. R. / Iori, R. / Ioannides, C. et al. | 2011
- 306
-
The stem cell gene ''inhibitor of differentiation 1'' (ID1) is frequently expressed in non-small cell lung cancerRothschild, S. I. / Kappeler, A. / Ratschiller, D. / Betticher, D. C. / Tschan, M. P. / Gugger, M. / Gautschi, O. et al. | 2011
- 312
-
A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significanceYun, J. / Son, C. H. / Um, S. J. / Kwon, H. C. / Lee, K. E. / Choi, P. J. / Roh, M. S. et al. | 2011
- 319
-
Fluorescent in situ hybridization (FISH) in the differential diagnosis of ground-glass opacities in the lungBettio, D. / Venci, A. / Cariboni, U. / Di Rocco, M. / Infante, M. et al. | 2011
- 323
-
Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST)Saghir, Z. / Ashraf, H. / Dirksen, A. / Brodersen, J. / Pedersen, J. H. et al. | 2011
- 328
-
Assessment of lung-cancer mortality reduction from CT ScreeningHenschke, C. I. / Boffetta, P. / Gorlova, O. / Yip, R. / DeLancey, J. O. / Foy, M. et al. | 2011
- 333
-
Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological studyKanzaki, R. / Higashiyama, M. / Fujiwara, A. / Tokunaga, T. / Maeda, J. / Okami, J. / Kozuka, T. / Hosoki, T. / Hasegawa, Y. / Takami, M. et al. | 2011
- 338
-
Definitive radiotherapy plus regional hyperthermia with or without chemotherapy for superior sulcus tumors: A 20-year, single center experienceMoon, S. D. / Ohguri, T. / Imada, H. / Yahara, K. / Yamaguchi, S. / Hanagiri, T. / Yasumoto, K. / Yatera, K. / Mukae, H. / Terashima, H. et al. | 2011
- 344
-
Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicityReinfuss, M. / Mucha-Malecka, A. / Walasek, T. / Blecharz, P. / Jakubowicz, J. / Skotnicki, P. / Kowalska, T. et al. | 2011
- 350
-
Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lungNose, N. / Uramoto, H. / Iwata, T. / Hanagiri, T. / Yasumoto, K. et al. | 2011
- 356
-
Geminin expression in small lung adenocarcinomas: Implication of prognostic significanceHaruki, T. / Shomori, K. / Hamamoto, Y. / Taniguchi, Y. / Nakamura, H. / Ito, H. et al. | 2011
- 363
-
Characteristics, treatment patterns and outcomes of patients with small cell lung cancer-A retrospective single institution analysisHermes, A. / Waschki, B. / Gatzemeier, U. / Reck, M. et al. | 2011
- 367
-
Acute onset of brain atrophy and dementia in a patient with small cell lung cancer: A case reportAsano, M. / Fujimoto, N. / Gemba, K. / Wada, S. / Ono, K. / Ozaki, S. / Adachi, Y. / Yamamoto, H. / Kishimoto, T. et al. | 2011
- 370
-
Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma modelShi, Y. / Hollenstein, A. / Felley-Bosco, E. / Fraefel, C. / Ackermann, M. / Soltermann, A. / Weder, W. / Stahel, R. / Pruschy, M. / Opitz, I. et al. | 2011
- 371
-
HER-2/neu expression is consistent in primary and metastatic lung adenocarcinomaFassan, M. / Rea, F. / Pizzi, M. / Rugge, M. et al. | 2011
- 372
-
Creating ''denial'' typologies is ontologically questionableSalander, P. et al. | 2011
- S1
-
3 Maximising archival resources to unravel the transcriptome of squamous cell carcinomaBrown, L. / Joseph, L. / Dale, C. / Ashton, G. / Pepper, S. / Landberg, G. / Barber, P. V. / Booton, R. et al. | 2011
- S2
-
6 The expression and role of thromboxane synthase in NSCLC: correlation with angiogenic factors and patient survivalCathcart, M. C. / Gately, K. / Cummins, R. / Kay, E. / Pidgeon, G. P. / OByrne, K. J. et al. | 2011
- S4
-
12 Use of erlotinib in management of recurrent advanced non-small cell lung cancer. The West Of Scotland experienceHameed, H. / Nasim, M. Y. / Dunlop, D. J. et al. | 2011
- S5
-
15 An audit of follow-up practice following completion of first-line chemotherapy for patients with advanced NSCLC at St Jamess Institute Of Oncology, LeedsSalter, A. / Mulatero, C. W. / White, J. et al. | 2011
- S9
-
27 10 years experience of malignant pericardial effusions from a tertiary referral centreCoyle, C. / Singh, N. / Nolan, L. et al. | 2011
- S11
-
33 Does modality of biopsy impact on ability to determine EGRF status in non-small cell lung cancer?Pond, Z. / Punwani, R. / Bishop, L. et al. | 2011
- S12
-
36 Twelve months experience of EGFR mutation testing in the UKButler, R. / Williams, A. / Walker, G. / Marsh, N. et al. | 2011
- S13
-
39 Stage migration: lymph node dissection in the era of modern imaging and invasive staging for lung cancerKirmani, B. H. / Rintoul, R. / Win, T. / Magee, C. / Magee, L. / Choong, C. / Wells, F. C. / Coonar, A. S. et al. | 2011
- S15
-
45 Epidermal growth factor receptor (EGFR) mutation testing - the Manchester experienceMitchell, C. / Huong, Y. / Wallace, A. / Summers, Y. / Doran, H. / Bishop, P. / Blackhall, F. et al. | 2011
- S16
-
48 Indwelling pleural catheters reduce inpatient stay for patients with malignant pleural effusionMunson, C. F. / West, D. G. / Vasey, L. / Kirk, A. J. et al. | 2011
- S17
-
50 Malignant mesothelioma in the North West - are diagnostic delays affecting survival?Thomson, D. / Hoyle, J. / Quennell, P. et al. | 2011
- S18
-
53 Principal results of the feasibility phase of the Mesothelioma and Radical Surgery trial (MARS-feasibility)Treasure, T. / Bliss, J. M. / Tan, C. / Entwisle, J. / Waller, D. / OBrien, M. / Coombes, G. / Webster-Smith, M. / Kilburn, L. S. / Snee, M. P. et al. | 2011
- S19
-
56 Expression of PTEN in malignant pleural mesotheliomaAgarwal, V. / Beaumont, K. L. / Campbell, A. / Lind, M. J. / Cawkwell, L. et al. | 2011
- S22
-
66 Red flag lung cancer clinic expediates patient pathway in lung cancerRingrow, S. M. / Ranaghan, E. / Warke, T. J. / Magee, N. et al. | 2011
- S23
-
68 Evaluating the use of holistic needs assessment tools with patients with lung cancerHalkyard, E. / Fenemore, J. / Roberts, J. / Beattie, V. / Borthwick, D. / Bell, N. et al. | 2011
- S24
-
72 Promoting smoking cessation for patients receiving treatment for lung cancerDowd, I. / Griffiths, N. et al. | 2011
- S25
-
75 The Mesothelioma Nurse Action Team: developing a national mesothelioma patient information pathwayDarlison, L. / Slade, G. / Moore, S. et al. | 2011
- S26
-
78 An evaluation of the benefits of the nurse practitioner role to thoracotomy patients and staff in the West of Scotland Heart and Lung CentreDevenay, S. et al. | 2011
- S27
-
81 The presentation and management of thymic epithelial malignancies & the Guys and St Thomas hospital experienceKrieger, L. E. / Lal, R. / Lang-Lazdunski, L. / Harrison-Phipps, K. / Chowdhury, F. et al. | 2011
- S28
-
83 Early results of a newly developed patient reported experience measure for the National Improving Lung Cancer Outcomes ProjectDraffan, J. / Christie, S. / Martin, L. / Lally, S. / Woolhouse, I. et al. | 2011
- S29
-
86 Management of malignant pleural effusions with tunnelled pleural catheters: a single institution experienceNoble, J. / Eaton-Smith, M. / Brouns, M. / Jones, R. M. / Thomas, J. et al. | 2011
- S30
-
89 Repeat local validation of the National Lung Cancer Database (LUCADA) in 2006 and 2009 - how do they compare?Calvert, L. / Chatterji, S. / Hollingdale, A. / Gregory, D. / Allingham, I. / Fife, K. et al. | 2011
- S31
-
91 Success of bedside talc slurry pleurodesis for malignant pleural effusions: a retrospective analysisPunwani, R. / Devlin, J. / Marshall, H. / Laws, D. et al. | 2011
- S32
-
94 Audit on outcome of patients with brain metastases treated with palliative whole brain radiotherapy (WBRT) over a period of 12 months, a single institutions experienceChaw, C. L. / Lord, H. K. et al. | 2011
- S34
-
99 Comparison of 4DCT derived PTV vs. free-breathing derived PTV in patients receiving radical radiotherapy for NSCLC - volumetric and dosimetric analysisFranklin, A. / Jones, M. / Barnard, A. / Illsley, M. / Ezhil, V. et al. | 2011
- S35
-
102 Radical radiotherapy outcomes in stage I and II non-small cell lung cancer patients unfit for surgeryEkatah, G. / Lord, H. K. et al. | 2011
- S37
-
107 Treatment with continuous, hyperfractionated, accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from two UK centresLester, J. E. / Das, T. / Esler, C. / Branagan, J. / Hatton, M. Q. et al. | 2011
- S39
-
114 Lung stereotactic body radiotherapy (SBRT) for medically inoperable peripheral stage 1 non-small cell lung cancer (NSCLC): updated results from St Jamess Institute of Oncology, LeedsSangha, V. / Prestwich, R. / Lilley, J. / Needham, A. / Summers, H. / Turner, R. N. / Snee, M. P. / Franks, K. N. et al. | 2011
- S40
-
117 CONVERT: Concurrent Once-Daily Versus Twice-Daily Radiotherapy - a phase III randomised controlled trial for patients with LS SCLC and good performance statusFaivre-Finn, C. / Falk, S. et al. | 2011
- S41
-
120 Role of PET scanning in upstaging of small cell lung cancer (SCLC)Teo, M. Y. / Feeney, J. N. / Downey, F. P. / McDermott, R. S. / Osman, N. / Walshe, J. M. et al. | 2011
- S45
-
Author index| 2011
- v
-
Contents| 2011
-
23 Experience of erlotinib for non-small cell lung cancer (NSCLC) at the Exeter Oncology CentreMinear, F. G. / Ward, A. J. / Dorey, N. E. / Osborne, M. E. / Toy, E. W. et al. | 2011
-
14 Results of patient satisfaction survey conducted across SE Wales on patients undergoing chemotherapy for lung cancerBrewster, A. / Jordan, C. / Gunter, T. / Poole, S. / Button, M. / Hanna, L. / Stevens, R. / Lester, J. F. et al. | 2011
-
119 Phase I dose finding study of irinotecan in combination with carboplatin in treatment naive extensive stage small cell lung cancerNolan, L. / Bradbury, J. A. / Muthuramalingam, S. / Cave, J. / Johnson, P. W. / Ottensmeier, C. H. / Crabb, S. C. et al. | 2011
-
34 Prevalence of activating epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer at Glenfield Hospital LeicesterAhmed, S. et al. | 2011
-
93 Cone-beam CT (CBCT) assessment of intra-fraction motion during stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC)Qureshi, A. / Hartill, C. / Landau, D. / Ahmad, S. et al. | 2011
-
52 Expression of the receptor MST1R/RON and its ligand MSP in malignant pleural mesotheliomaGray, S. G. / Easty, D. / Baird, A. M. / Opitz, I. / Nonaka, D. / Fennell, D. A. / Pass, H. I. / Mutti, L. / Solterm, A. / OByrne, K. J. et al. | 2011
-
17 An audit of the uptake of adjuvant chemotherapy following surgery with curative intent in NSCLC patients at St Jamess Institute of Oncology, LeedsGeorge, D. R. / Mulatero, C. W. et al. | 2011
-
84 Raising the profile of lung cancer: the role of the UK Lung Cancer CoalitionPeake, M. D. / Shovelton, H. / Tovey, H. et al. | 2011
-
85 Breathlessness in advanced intrathoracic malignancy - a framework for interventionPeel, T. / Wood, H. / Dogan, S. / Connors, S. et al. | 2011
-
95 Audit of the management of spinal cord compression (pre-NICE guideline implementation)Gahir, D. / Esler, C. et al. | 2011
-
108 Radical vs high-dose palliative radiotherapy in NSCLC patients over 75 at Plymouth Hospitals NHS TrustMeissner, M. / Minear, F. G. / Roy, A. E. et al. | 2011
-
25 EGFR mutation analysis in Welsh populationRimi, F. T. / Ghosal, N. / Shrimali, R. K. / Stuart, N. / Lester, J. F. / Bale, C. / Williams, R. / Garcia, A. et al. | 2011
-
2 Expression of the CXC (ELR+) receptor, CXCR2, is reactivated by epigenetic means in non-small cell lung cancerBaird, A. M. / Gray, S. G. / OByrne, K. J. et al. | 2011
-
63 Use of a feedback questionnaire to improve effectiveness of MDTHoda, U. / Dockree, E. / Succony, L. / Byers, E. / Win, T. et al. | 2011
-
103 Impact of integration of fused FDG-PET and CT information for GTV delineationWebster, G. J. / Harris, M. / Tout, D. / Julyan, P. / Rowbottom, C. / Burt, P. A. / Hulse, P. / Faivre-Finn, C. et al. | 2011
-
96 An audit of the use of radiotherapy for brain metastases from lung cancerGahir, D. / Esler, C. et al. | 2011
-
4 VEGF is an autocrine survival factor in non-small cell lung cancerBarr, M. / Gately, K. / OByrne, K. J. et al. | 2011
-
22 Does histological subtype determine response to chemotherapy in advanced non-small cell lung cancer? A retrospective studyWalkington, L. A. / Woll, P. J. et al. | 2011
-
30 Neck ultrasound and cervical lymph node sampling reduces time to diagnosis for lung cancerWilsmore, N. / Free, C. M. / Agrawal, S. / Raj, V. / Bajaj, A. / Bennett, J. A. et al. | 2011
-
20 The use of erlotinib in NSCLC at the Christie HospitalHussain, J. / Harris, M. / Woolley, J. et al. | 2011
-
37 Experiences in epidermal growth factor receptor tyrosine kinase mutation testing in South East WalesCurrie, S. / Butler, R. / Tanguay, J. / Button, M. / Brewster, A. / Stevens, R. / Lester, J. F. et al. | 2011
-
73 A lung cancer study day can improve awareness of prognosis amongst allied healthcare professionalsPhelps, J. / Palmer, M. / Barber, J. / Powrie, D. / Waker, B. / Idowu, B. et al. | 2011
-
Editorial Board| 2011
-
47 Pemetrexed for malignant pleural mesothelioma (MPM): updated experience in Northern IrelandFenton, A. / Harney, J. / Stewart, D. / Scullin, P. et al. | 2011
-
62 Does GP clinical history influence radiologists interpretation of chest radiographs or reliably predict eventual diagnosis of lung malignancy?Chatterji, S. / Calvert, L. / Fife, K. / Bond, S. et al. | 2011
-
10 Targeting the IGF-1R signalling pathway in non-small cell lung cancer (NSCLC)Forde, L. / Gately, K. / Gray, S. G. / OByrne, K. J. et al. | 2011
-
111 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part two, symptoms, quality of life and data completionMulvenna, P. / Barton, R. / Faivre-Finn, C. / Wilson, P. / Langley, R. / Pugh, C. / Nankivell, M. et al. | 2011
-
11 Second-line erlotinib in unselected NSCLC: audit of benefitUrquhart, G. / Semple, E. / Steven, E. / Kerr, K. / Nicolson, M. et al. | 2011
-
77 A multidisciplinary complex perioperative intervention to reduce complications and enhance recovery after lung resection surgeryAbdelaziz, M. / Bradley, A. / Agostini, P. / Jordan, C. / Reaper, L. / Gillies, J. / Stonehewer, L. / Naidu, B. et al. | 2011
-
97 Implementation of stereotactic body radiotherapy (SBRT) for non-small cell lung cancers in the UK: update from the SBRT ConsortiumJain, P. / Franks, K. N. / Lilley, J. / Landau, D. / Mohammed, N. / Peedell, C. / Hatton, M. Q. et al. | 2011
-
59 A joint non medical prescribing clinic for the management of patients requiring tyrosine kinase inhibitors and chemotherapy treatments led by a lung cancer clinical nurse specialist and a Macmillan pharmacistBowden, E. M. / Horne, N. et al. | 2011
-
112 Set-up corrections for lung stereotactic body radiotherapy (SBRT) patients determined by online cone beam CT image guidancePeedell, C. / Richmond, C. / Pilling, K. / Shakespeare, D. / Bayles, H. / Huntley, C. / Green, J. / Walker, C. et al. | 2011
-
31 Histolopathological trends in HIV-associated lung cancerMerchant, S. / Marouf, A. / Hachach-Haram, N. / Nelson, M. / Bower, M. / Newsom-Davis, T. et al. | 2011
-
116 Oral topotecan in platinum-refractory small-cell lung cancer: A cancer network experienceStephens, P. / Woolcock, S. / Gardiner, J. et al. | 2011
-
98 A paradigm shift IMRT enables radical treatment in locally advanced lung cancer patients who would have been treated with palliative intent with 3D conformal radiotherapy (3D CRT)Shrimali, R. K. / Webster, G. J. / Lee, L. W. / Bayman, N. / Sheikh, H. Y. / Bewley, M. / Burt, P. A. / Faivre-Finn, C. et al. | 2011
-
65 Are we achieving lung cancer waiting time guidelines?Connolly, E. / Burt, P. A. et al. | 2011
-
55 Expression of5&12 lipoxygenase in malignant pleural mesotheliomaAgarwal, V. / Ranatunge, D. / Campbell, A. / Lind, M. J. / Cawkwell, L. et al. | 2011
-
126 Surgery of tumours invading the thoracic inlet (pancoast tumours): a contemporary experienceLang-Lazdunski, L. / Bille, A. / Ahmad, S. / Landau, D. et al. | 2011
-
122 Small cell lung carcinoma: experience in patients treated with initial chemotherapy or sequential chemotherapy plus radiotherapy 2005-2010Taylor, P. / Akram, Z. / Out, C. / Summers, Y. / Thatcher, N. et al. | 2011
-
28 CT guided lung biopsy - providing patient information in a multidisciplinary settingBorthwick, D. / Minns, F. C. / Ni Mhuineachain, A. / Murcheson, J. et al. | 2011
-
82 Investigating physical activity levels of lung cancer patients pre-intervention and feasibility of exercise class attendance post-interventionSchofield, E. M. / Ward, C. A. / Elkin, S. L. et al. | 2011
-
76 A multi-professional health and well being clinic incorporating holistic needs assessmentGuerin, M. / Beattie, V. / Bayley, J. et al. | 2011
-
42 Endobronchial ultrasound (EBUS)-guided transbronchial biopsy/brush of peripheral pulmonary nodules: an initial cancer centre experienceBrown, L. / Chaturvedi, A. / Doran, H. / Joseph, L. / Bishop, P. / Barber, P. V. / Booton, R. et al. | 2011
-
115 Audit of high dose palliative radiotherapy survival outcomes in patients with non-small cell lung cancer (NSCLC) in Leeds between 1999 and 2009Murray, P. F. / Illsley, A. L. / Bond, M. G. / Bottomley, D. M. / Franks, K. N. / Henry, A. M. / Snee, M. P. / Turner, R. N. et al. | 2011
-
29 In the absence of EBUS, blind TBNA is an important tool for patients with suspected thoracic malignancyShepherd, K. / Brown, L. / Bishop, P. / Joseph, L. / Doran, H. / Martin, J. / Barber, P. V. / Booton, R. et al. | 2011
-
106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the ChristieHelbrow, J. / Bayman, N. / Burt, P. A. / Chittalia, A. / Harris, M. / Lander, H. / Lee, L. W. / Pemberton, L. / Sheikh, H. Y. / Malloy, L. et al. | 2011
-
7 Expression and regulation of IL-23 in NSCLCGray, S. G. / OByrne, K. J. / Kilmartin, L. / Leonard, J. et al. | 2011
-
5 The generation and characterisation of cisplatin resistant non-small cell lung cancer cell lines that display stem-like featuresBarr, M. / Fennell, D. A. / OByrne, K. J. et al. | 2011
-
128 Primary lung cancer surgery should be done by VATS (video assisted thoracoscopic surgery)Mehta, V. / Royston, E. / Nicholson, J. / Sayeed, R. / Black, E. et al. | 2011
-
58 SCAN Lung Group - a patient satisfaction surveyBorthwick, D. / Little, F. et al. | 2011
-
100 Continuous hyperfractionated accelerated radiotherapy (CHART) for patients with inoperable non-small cell lung Cancer (NSCLC): 10 year experience of the Exeter Oncology CentreAlip, A. / Toy, E. W. et al. | 2011
-
70 Dying from lung cancer - a study of end of life careShipley, M. D. / Ward, A. J. / Echevarria, C. et al. | 2011
-
1 Vitamin D axis in lung cancerMillen, A. / Steyn, R. S. / Rajesh, P. B. / Kalkat, M. S. / Rock, G. / Langman, G. / Wood, A. / Naidu, B. et al. | 2011
-
54 University Hospitals of Leicester mesothelioma audit 2006-2009Brown, V. / Darlison, L. / Ahmed, S. et al. | 2011
-
61 Reducing emergency admissions to hospital through the introduction of an acute lung cancer clinicHodgson, L. / Doffman, S. / Messenger, J. / Mason, L. et al. | 2011
-
40 Improved resection rates following a campaign to raise awareness of cough as an early lung cancer symptomAthey, V. / Suckling, R. / Rogers, T. K. et al. | 2011
-
16 Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern IrelandMulligan, C. / Campbell, L. / McAleese, J. / Scullin, P. et al. | 2011
-
44 Bimodality surveillance of patients at high risk for lung cancerBrown, L. / Dale, C. / McCalman, K. / Martin, J. / Barber, P. V. / Booton, R. et al. | 2011
-
88 Using multimedia information to improve outcomes for lung cancer patients and carersDickson, J. et al. | 2011
-
125 Vertical ribs osteosynthesis system (VEPTR) combined with ePTFE: a modern reconstruction of a large posterolateral chest wall defect after en-bloc resection for vertebral-T4 NSCLCBerthet, J. P. / Canaud, L. / DAnnoville, T. / Alric, P. / Attard, O. / Marty-An, C. H. et al. | 2011
-
18 NSCLC second line therapy with erlotinib: review of patients outcomesUrquhart, G. / Semple, E. / Steven, E. / Kerr, K. / Nicolson, M. et al. | 2011
-
127 PulMiCC (Pulmonary Metastasectomy in Colorectal Cancer) trialTreasure, T. et al. | 2011
-
87 Is there a need for prospective international database for thymomas?Nagarajan, K. / Dudek, W. / Langman, G. / Naidu, B. / Kalkat, M. S. / Bishay, E. S. / Steyn, R. S. / Rajesh, P. B. / Abdelaziz, M. et al. | 2011
-
21 The survival benefit of erlotinib in the management of advanced non-small cell lung cancer (NSCLC) in the routine clinical practice; a retrospective studyDaverede, L. / Elmahdawi, N. / Scott, C. / Bozas, G. / Upadhyay, S. / Dhadda, A. / Butt, M. et al. | 2011
-
9 EGFR mutation in non-small cell lung cancer: one year of laboratory testingdu Parcq, P. A. / Jones, P. / Nelson, J. / Miller, K. / Diss, T. et al. | 2011
-
13 The predictive value of serum tumour markers in Tyrosine Kinase Inhibitor (TKI) treatment for advanced non-small cell lung cancer (NSCLC)Pearmain, L. / Crawford, S. M. et al. | 2011
-
19 A Kent and Medway Cancer Network (KMCN) audit of first-line treatment with cisplatin/pemetrexed (CisPem) in non squamous non-small cell lung cancer (NSCLC)Letsa, I. / Mikropoulos, C. / Burcombe, R. / Visioli, A. / Sevitt, T. / Cominos, M. / Beesley, S. et al. | 2011
-
104 Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatmentEldeeb, H. / Camilleri, P. / Mak, E. / Siddiqui, A. et al. | 2011
-
74 Lung cancer patients/carers support - what do they really want?Smith, K. J. / Rowe, S. et al. | 2011
-
49 Proteomic analysis of the mechanism of action of a COX2 Inhibitor (DuP-697) in mesotheliomaAgarwal, V. / Hodgkinson, V. C. / Eagle, G. L. / Scaife, L. / Lind, M. J. / Cawkwell, L. et al. | 2011
-
92 Junior doctors confidence around prescribing opiates in thoracic oncology: a survey from a teaching hospital in Bristol, South West EnglandLeahy, A. / Cooper, L. et al. | 2011
-
51 Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and adjuvant chemotherapy in patients with malignant pleural mesothelioma. A 6-year experienceLang-Lazdunski, L. / Bille, A. / Belcher, E. / Landau, D. / Steele, J. / Taylor, H. / Spicer, J. et al. | 2011
-
46 Prevalence of EGFR and K-RAS mutation status in clinical practice - relationship to patient characteristicsSimpson, T. / Pennycuick, A. / Crawley, D. / Tobal, K. / Santis, G. et al. | 2011
-
101 Radical radiotherapy outcomes for non-small cell lung cancer (NSCLC) - Barts experience 2000-2008Eminowicz, G. / Raman, R. / Tarver, K. / Wells, P. et al. | 2011
-
71 Telephone support by lung cancer nurses: results of a national studyDutton, H. et al. | 2011
-
26 Improving patient comfort during medical thoracoscopyPowell, H. A. / Collins, C. / Rowe, S. / Smith, K. J. / Whale, C. I. et al. | 2011
-
109 Patients with non-small cell lung cancer and brain metastases who received whole brain radiotherapy were they considered for the Quartz trial?Wilson, P. / Ayre, G. / Owadally, W. / Gray, E. et al. | 2011
-
32 Can EBUS/EUS FNA specimens be used to accurately assess cell type in non-small cell lung carcinomas?Wallace, W. / Rassl, D. et al. | 2011
-
90 The National Lung Cancer Audit - year 5 completeness and outcomes and case-mix adjustmentBeckett, P. / Stanley, R. / Woolhouse, I. / Peake, M. D. et al. | 2011
-
38 Testing for epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based analysis in North TrentDas, T. / Durkie, M. / Woll, P. J. / Hatton, M. Q. / Mohanamurali, J. / Lee, C. / Fisher, P. M. / Danson, S. et al. | 2011
-
80 Evaluating the care and experiences of patients with spinal cord compressionWarnock, C. / Tod, A. M. et al. | 2011
-
41 Adequacy of EBUS transbronchial needle aspirates to facilitate the histological sub-classification of thoracic malignancyBrown, L. / Chaturvedi, A. / Bishop, P. / Joseph, L. / Doran, H. / Shah, R. / Krysiak, P. / Martin, J. / Barber, P. V. / Booton, R. et al. | 2011
-
124 Predictive prognostic factors of surgically treated intra-pulmonary metastases from colorectal carcinomas: a 30 years retrospective analysisGranato, F. / Kirk, A. J. / Spina, D. / Bellan, C. / Cetta, F. / Bongiolatti, S. / Gotti, G. et al. | 2011
-
118 Syndrome of inappropriate antidiuretic hormone (SIADH) in patients with small cell lung cancer & incidence and response to treatmentJellett, L. / OHare, J. / McAleese, J. et al. | 2011
-
121 STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trialWoll, P. J. / Jarrett, H. / Billingham, L. et al. | 2011
-
35 The first 12 months of UK diagnostic services for EGFR gene mutations in NSCLC patientsButler, R. / Clark, C. / Deans, Z. / Durkie, M. / Gonzalez, D. / Taniere, P. / Wallace, A. et al. | 2011
-
110 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part one, baseline characteristics, survival and QALYsMulvenna, P. / Barton, R. / Faivre-Finn, C. / Wilson, P. / Langley, R. / Pugh, C. / Nankivell, M. et al. | 2011
-
43 Variations in practice of intraoperative staging for lung cancer resectionSharkey, A. / Downing, J. / Rao, J. / Hopkinson, D. / Locke, T. / Edwards, J. et al. | 2011
-
79 Audit of correct administration of DVT prophylaxis for patients undergoing thoracic surgery for the resection of pulmonary carcinomasLodge, C. / Stamenkovic, S. / Slight, R. et al. | 2011
-
113 Cone beam computed tomography (CBCT) based adaptive radiotherapy for lung cancer? The Christie experienceShrimali, R. K. / Webster, G. J. / Lee, L. W. / Bayman, N. / Sheikh, H. Y. / Stratford, J. / Chauhan, S. / Faivre-Finn, C. et al. | 2011
-
123 Small cell lung cancer overall survival, incidence of brain metastases and use of prophylactic cranial irradiation for patients treated in Cambridge during 2005-2009Harden, S. V. / Saunders, D. / Magee, L. / Ainsworth, N. et al. | 2011
-
60 The use of distress scores in a dedicated lung cancer clinicHodgson, L. / Doffman, S. / Messenger, J. / Mason, L. et al. | 2011
-
57 Effectiveness of decision making at lung cancer multidisciplinary team meetingsStorrar, W. / Laws, D. et al. | 2011
-
105 Survival outcomes following high dose palliative thoracic radiotherapySaid, J. / Barrie, C. S. / Lord, H. K. et al. | 2011
-
8 Vitamin D levels in patients with lung cancer: a potential cause of confusion?Said, J. / Barrie, C. S. / Rankin, E. M. et al. | 2011
-
67 Retrospective audit of a district general hospital (DGH) lung multi-disciplinary team (MDT) - lessons from misses and near-misses of treatment deadlineOConnor, S. J. / Elliott, S. / Chinegwundoh, J. / Popat, S. / Rhode, A. L. et al. | 2011
-
64 Patient choice in lung cancer at the East and North Hertfordshire NHS TrustSuccony, L. / Dockree, E. / Blake, A. / Hoda, U. / Win, T. et al. | 2011
-
69 Evaluation of an educational intervention - an everyday toolbox for the management of breathlessness in advanced diseaseHillcox-Smith, A. / Knight, K. et al. | 2011
-
24 A cost-effectiveness analysis on the use of erlotinib (Tarceva) in the maintenance treatment of locally advanced or metastatic NSCLC patients with stable disease (SD) as best response to inductionMcNamara, S. / Nuijten, M. / Summerhayes, M. / Ray, J. / Walzer, S. et al. | 2011